Quick access to main page (top) Direct access to main contents Quick access to main page (bottom)

U.S. and Allies to Discuss High-Tech Bio Collaboration and Chinese Competition

Daniel Kim Views  

High-ranking officials from South Korea, the United States, Japan, and India are set to convene at BIO USA 2024 to discuss strategies for advancing the industry. The summit will mainly address critical issues such as strengthening pharmaceutical supply chains but it may also touch upon the U.S.’s efforts to counter the influence of Chinese biotech firms.

According to government and industry sources, the meeting will take place on June 5th in San Diego, California. Delegates from the four nations will gather to explore collaborative initiatives in the biotech field, coinciding with the BIO USA 2024 conference, which runs from June 3 to 7.

After touring the BIO USA exhibition, representatives from each country will meet at the venue on the third day of the event for the summit.

The summit serves as a follow-up to the Next Generation Critical and Emerging Technologies Dialogue held in Seoul last December. During the last summit, the two nations agreed to enhance research collaboration and fortify the pharmaceutical supply chain by launching the Bio 1.5 Track Channel, a platform involving both government and pharmaceutical companies.

The upcoming meetings are expected to delve into specific research collaboration strategies and operational details for the Bio 1.5 Track Channel. Upon the United States’ request, representatives from India and Japan are to attend the summit with the possibility of the European Union’s (EU) involvement. South Korea will be represented by 2-3 secretaries, including the Presidential Secretary for Advanced Biotech, and a director-general from the Ministry of Health and Welfare.

There is speculation that the agenda may include discussions on the U.S.’s measures against Chinese biotech firms. The recently passed Biosecurity Act by the U.S. House of Representatives aims to prevent American patient data and taxpayer money from reaching biotech companies in adversarial nations. The law specifically targets five Chinese firms, including WuXi Biologics and BGI. If enacted, the companies will be prohibited from entering equipment and service contracts in the U.S. starting January 1, 2032. This development indicates an expansion of the U.S.-China economic rivalry into the biotech industry, as seen in similar tensions in the semiconductor and IT sectors.

The presence of South Korean Contract Development and Manufacturing Organizations (CDMOs) like Samsung Biologics and CHA Biotech at this year’s BIO USA—one of the largest contingents to date—reflects the shifting dynamics influenced by the U.S.’s stance on China.

A biotech industry insider noted, “As economic cooperation shifts to economic security, biotech companies are beginning to feel the impact of the U.S.-China conflict. While the U.S. Biosecurity Law is expected to benefit South Korean CDMO companies, considering the entire biotech industry, the Chinese market is also important, so flexible responses are needed.”

Daniel Kim
content@viewusglobal.com

Comments0

300

Comments0

[LATEST] Latest Stories

  • BMW's Next-Gen EV: The Bold New i3 Touring Concept Revealed
  • LEGO Technic Ferrari SF-24 F1 Car: A 1,361-Piece Tribute to Ferrari’s 2024 F1 Season
  • Hyundai’s Ioniq 6 Just Took the Top Spot in J.D. Power’s EV Ownership Study
  • Jeep’s Recon: The Next-Gen 600HP Electric SUV Ready to Tackle the Market
  • Tesla Issues Recall for 376,000 Vehicles Due to Steering Assist Malfunction
  • Ferrari Reveals 499P Livery and Driver Lineup for 2025 World Endurance Championship

You May Also Like

  • 1
    Dining Out While Dieting: 10 Healthy Restaurant Meals You Can Enjoy

    LIFESTYLE 

  • 2
    How Real People Shaped Disney’s Most Beloved Animated Characters

    ENTERTAINMENT 

  • 3
    Why Olive Oil is the Ultimate Wellness Food You Shouldn't Overlook

    LIFESTYLE 

  • 4
    Is Barefoot Walking the Secret to Better Circulation and Less Stress?

    LIFESTYLE 

  • 5
    Actress Swears by Morning Saltwater—Doctors Say Don’t Overdo It

    LIFESTYLE 

Popular Now

  • 1
    Sweet and Salty? Tastes Great, But Here's What It's Doing to Your Body

    LIFESTYLE 

  • 2
    Yogurt: Diet Savior or Sneaky Saboteur? Here's What You Should Know

    LIFESTYLE 

  • 3
    Blackberries vs. Raspberries: Which Berry Is the Low-Calorie King?

    LIFESTYLE 

  • 4
    Why Some People Gain Weight on Salads—and Others Don’t

    LIFESTYLE 

  • 5
    This Vitamin Could Help You Fight Fatigue, Infections, and More

    LIFESTYLE 

Must-Reads

  • 1
    Dining Out While Dieting: 10 Healthy Restaurant Meals You Can Enjoy

    LIFESTYLE 

  • 2
    How Real People Shaped Disney’s Most Beloved Animated Characters

    ENTERTAINMENT 

  • 3
    Why Olive Oil is the Ultimate Wellness Food You Shouldn't Overlook

    LIFESTYLE 

  • 4
    Is Barefoot Walking the Secret to Better Circulation and Less Stress?

    LIFESTYLE 

  • 5
    Actress Swears by Morning Saltwater—Doctors Say Don’t Overdo It

    LIFESTYLE 

Popular Now

  • 1
    Sweet and Salty? Tastes Great, But Here's What It's Doing to Your Body

    LIFESTYLE 

  • 2
    Yogurt: Diet Savior or Sneaky Saboteur? Here's What You Should Know

    LIFESTYLE 

  • 3
    Blackberries vs. Raspberries: Which Berry Is the Low-Calorie King?

    LIFESTYLE 

  • 4
    Why Some People Gain Weight on Salads—and Others Don’t

    LIFESTYLE 

  • 5
    This Vitamin Could Help You Fight Fatigue, Infections, and More

    LIFESTYLE 

Share it on...